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Nicotinic acetylcboline receptors (AChRs) from muscle bind a-bungarotoxin (aBgt) and are composed of 
four kinds of subunits, whereas AChRs from mammalian brains do not bind aBgt and are composed of 
two kinds of subunits. aBgt-binding proteins whose function is unknown are also found in brain. All these 
proteins belong to the same gene family. The human medulloblastoma cell line TE671 expresses a functional 
AChR which binds aBgt. Surprisingly, the AChR of this neuron-derived cell line has electrophysiological, 
immunological and biochemical properties different from neuronal AChRs and very similar to muscle 
AChRs. The TE671 AChR binds crBgt, but is different from aBgt-binding proteins in brain. Here we show 
that TE671 expresses the a-subunit mRNA coding for the muscle AChR, thereby proving that TE671 ex- 
presses a muscle-type AChR that is not expressed in adult brain. The isolated cDNA clones should prove 
useful for expression of large amounts of human muscle-type AChR a-subunit protein for studies of the 
autoimmune response to muscle AChRs in human myasthenia gravis. 
Acetylcholine receptor; Myasthenia gravis; cDNA; (TE671 cell line) 
1. INTRODUCTION 
The nicotinic acetylcholine receptor (AChR) 
gene family includes AChRs from skeletal muscle, 
neurons, the neuronal cY-bungarotoxin (crBgt)- 
binding component and the more distantly related 
receptors for y-aminobutyric acid and glycine 
(review [ 11). 
AChRs from muscle are thought to closely 
resemble AChRs from Torpedo electric organ, 
which are formed from four different subunits ((Y, 
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p, y and 6). These are organized in the order 
a&yS, like barrel staves around a central cation 
channel [2]. The sites which bind acetylcholine 
(ACh) and aBgt and regulate channel opening are 
located on the a-subunits, near cysteines a192 and 
193 [3-51. 
AChRs purified from brain have been found to 
consist of only two kinds of subunits [6,7]. 
Although their ACh-binding subunits have cys- 
teines homologous to a192-193 of AChRs from 
muscle [g-lo], neuronal AChRs do not bind aBgt 
[6-121. 
cuBgt-binding proteins are found on neurons of 
ganglia [11,13] and brain [7,14,15], but aBgt does 
not block AChR-induced depolarization in these 
neuronal preparations [ 11,131. 
The human medulloblastoma cell line TE671 
[16] has been reported to have functional AChRs 
which are blocked by cvBgt [17]. It was assumed 
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Fig.1. Northern blot analysis of TE671 poly(A)+ RNA 
probed with mouse muscle AChR a-subunit cDNA. 
that these were a neuronal AChR type which could 
be blocked by LvBgt [17-191. 
Previously, we observed that AChRs from 
TE671 cells were immunologically similar to the 
AChR from human muscle [20,21] and im- 
munologically distinct from both human brain 
AChRs which did not bind aBgt and human aBgt- 
binding proteins [21]. Specifically, we observed 
that autoantibodies from myasthenia gravis (MG) 
patients reacted essentially as well as with AChR 
from TE671 cells as they did with AChRs from 
human muscle [20]. However, the MG patient sera 
did not react with either AChRs or cuBgt-binding 
proteins from human brains [21]. Recently we 
observed that, at the level of single channel func- 
tion, AChRs in TE671 cells resemble those found 
in muscle and that AChRs purified from TE671 
cells have four kinds of subunits which closely 
resemble those of AChRs from Torpedo electric 
organ (Luther, M. et al., in preparation). 
Fig.2. Analysis of TE 1.1 and TE 4.1 with deduced 
structural features of the AChR a-subunit. I? , 
glycosylation site at Asn-141; UT, untranslated region; 
L, leader peptide; Ml-M4, hydrophobic segments; 
-, intron sequence. 
Here we report the cloning and sequencing of a 
cDNA for the a-subunit of AChRs from TE671 
cells. The sequence shows extensive identity to cy- 
subunits of muscle AChRs from several species, 
and is identical to the sequence predicted by a 
human genomic clone previously reported by 
Numa and co-workers [22]. This proves that this 
neuronal cell line is expressing a-subunits identical 
to those of AChRs in muscle rather than a 
neuronal-type AChR which is blocked by cuBgt. 
2. MATERIALS AND METHODS 
2.1. Cell cultures 
TE671 cells were grown in Iscove’s modified 
Dulbecco’s minimal essential medium (Irvine 
Scientific) supplemented with 10% fetal bovine 
serum. 
2.2. Northern blot analysis 
DNA/RNA experiments were carried out, 
following standard procedures [23]. RNA isolation 
and Northern blot analysis were performed as 
described in [24] except hat RNA was blotted onto 
Hybond-N nylon membranes (Amersham) and 
UV-crosslinked. Poiy(A)+ RNA was obtained by 
oligo(dT) chromatography. 
2.3. cDNA library 
cDNA was synthesized by the RNase H method 
[25], following the protocol of Watson and 
Jackson [26]. cDNA > 1 kb was ligated into the 
cloning vector h-zap (Stratagene). Approx. lo5 
Fig.3. Nucleotide sequence of TE 1.1 with deduced amino acid sequence. The mature protein starts at position 1. 
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MetGluProTrpProLeuLeuLeuLeuPheSerLeuCysSsr 
AAGCACACCCCACCACTCTCCCCTGGTCCACACAACCTFCGGTAGCCC~TGGAGCCCT~GCCTCTCCT~CTGCTCTTT~GCCTTTGCT~A 
-108 -8i -8i -40 -20 
-1 1 20 
AlsGlyL~uVsIL~uGlyS~rGluHisGluThrArgLeuVslAl~LysLeuPh~Ly8AspTyrSerS~rVslV~lArgProVslGluAsP 
GCTGGCCT~GTCCTGGG~TCCGAACAT~AGACCCGTC?GGTGGCAAA~CTATTTAAA~ACTACAGCA~CGTGGTGCG~CCAGTGGAA~AC 
-1 1 20 40 60 
40 
HisArgGlnVsIV~IGluVsIThrVslGlyL~uGlnL~uIloGlnLouIleAsnVslAspGluVslAsnGlnIl~VslThrThrAsnVsl 
CACCGCC?GGTCGTGGACGTCACCGTG~GCCTGCAGC?GATACAGCT~ATCAATGTG~ATGAAGTAA~TCAGATCGT~ACAACCAAT~TG 
80 100 120 140 160 
60 80 
ArgLeuLysGlnGlnTrpVslAspTyrA~nLouLysTrpAsnProA~pAspTyrGlyGlyVslLysLysIlsHisIleProSsrGluLys 
CGTCTGA?ACAGCAATGCGTGGATTAC~ACCTAAAAT~GAATCCAGA?GACTATGGC~GTGTGAAAA~AATTCACAT?CCTTCAGAA~AG 
180 200 220 240 
100 
IleTrpArgProAspL~uVslL~uTyrAsnAsnAlsAspGlyAspPhoAlsIl~VslLysPhoThrLysVslLouLouGlnTyrThrGly 
ATCTGGCcCCCAGACCTTGTTCTCTAT~ACAATGCAG~TGGTGACTT?GCTATTGTC~AGTTCACCA~AGTGCTCCT~CAGTACACT~GC 
naa 28; 30e 328 340 
120 140 
HisIIoThrTrpThrProProAl~IlePhoLysSsrTyrCy~GluIleIloV~lThrHisPhsProPh~A8pGluGlnAsnCy8S~rMst 
CACATCA~GTGGACACC~CCAGCCATC?TTAAAAGCT~CTGTGAGAT~ATCGTCACC~ACTTTCCCT~TGATGAACA~AACTGCAGC~TG 
300 380 400 420 
160 
LysLsuGlyThrTrpThrTyrAspGiySorVslVslAlsIloAsnProGluSorAspGlnProAspLouSorAsnPhoMstGluSsrGly 
AAGCTGGCCACCTGGAClTACGACGGC?CTGTCGTGG~CATCAACCC~GAAAGCGAC~AGCCAGACC?GAGCAACTT~ATGGAGAGC~GG 
440 480 480 600 620 
180 200 
GluTrpVsIIIsLysGluSorArgGlyTrpLysHi8SorV~lThrTyrSorCysCysProAspThrProTyrLouAspIloThrTyrHis 
GAGTGGGTGATCAAGGAoTCCCGGGGC?GGAAGCACT~CGTGACCTA?TCCTGCTGC~CCGACACCC~CTACCTGGA~ATCACCTAC~AC 
640 680 680 800 
220 
Ph~VsIMstGlnArgLouProLouTyrPhoIloVslA~nVslIloIloProCysLouLouPhsSsrPhsLsuThrGlyL~uVslPhoTyr 
TTCGTCA~GCAGCGCCT~CCCCTCTAC~TCATCGTCA~CGTCATCAT~CCCTGCCTG~TCTTCTCCT~CTTAACTGG~CTGGTATTC?AC 
620 640 660 880 700 
240 280 
LsuProThrAspSerGlyGIuLysMetThrLeuSerIleSerVslLeuL~uSerLeuThrVslPh~LeuLeuVslIl~VslGluLsuIle 
CTGCCCAFAGACTCAGG~GAGAAGATG~CTCTGAGCA?CTCTGTCTT~CTGTCTTTG~CTGTGTTCC?TCTGGTCAT~GTGGAGCTG~TC 
720 780 780 
ProSsrThrS~rSsrAlsVslProLeuIloGlyLysTyrMotLouPheThrMstVslPhoV~lIleAl~S~rIlsIleIlsThrVslIl~ 
CCCTCCA~GTCCAGTGC~GTGCCCTTG~TTGGAAAAT~CATGCTGTT~ACCATGGTG~TCGTCATTG~CTCCATCAT~ATCACTGTC~TC 
800 820 840 860 880 
300 320 
VsIII~AsnThrHisHisArgSsrProSorThrHisVslMetProAsnTrpV~lArgLysV~lPheIloAspThrIleProA8nIl~Met 
GTCATCA?CACACACCAFCGCTCACCC~GCACCCATG?CATGCCCAA~TGGGTGCGG~AGGTTTTTA?CGACACTAT~CCAAATATC~TG 
sapr 94; see 
- ._ 
PhsPhoSerThrMetLysArgProSorArgGluLysGlnAspLysLysIlePhoThrGluAspIleAspllsSorAspIlsSorGlyLys 
TTTTTCTFCACAATGAA?AGACCATCC?ACACAAAAA~ATTTTTACA~AAGACATTG~TATCTCTGA~ATTTCTGGA~AG 
ge0 1000 1020 1040 1060 
360 380 
ProGlyProProProM~tGIyPhoHisSorProLouIleLysHi~ProGluVslLysS~rAlsIloGluGlyIleLysTyrIlsAlsGlu 
CCAGGGCCTCCACCCATCGGCTTCCAC?CTCCCCTGA?CAAACACCC~GAGGTGAAA~GTGCCATCG~GGGCATCAA~TACATCGCA~AG 
1080 1100 1120 1140 
ThrMstLysSerAspGlnGIuSerAsnAsnAl~AlsAlsGluTrpLysTyrV~lAlsM~tVslMotAspHisIleL~uLeuGlyVslPhe 
ACCATGA?GTCAGACCAcGAGTCTAAC~ATGCGGCGG~AGAGTGGAA~TACGTTGCA~TGGTGATGG~CCACATACT~CTCGGAGTC?TC 
1160 1180 1200 1220 1240 
420 
M~tLeuVsICysIIsII~GIyThrLsuAlsVslPh~AlsGlyArgLouIleGluLouAsnGlnGlnGlyEnd 
ATGCTTGTTTGCATCAT”GGAACCCTA~CCGTGTTTG~AGGTCGACT~ATTGAATTA~ATCAGCAAG~ATGAGCAGA~AATGAGCTG~GC 
1260 1280 1300 7 320 
TTAGCTCTGCCCTGGAAFCTACCAGAG~AGAGAAGGG~AGGAGAGGA~GATTTGTCT~CTTGCTCCA~TCGCACTTA?CAAACGTGT?AT 
1340 1380 1380 1400 1420 
ATTCCAT?CTTATTATTGATGATAAGA?TTACCTTTA?GTAAGTTTA?GGCCTTGAA~TGTTTTCAT~TTGCTTCTC~CTTTAGTTC?GC 
1440 1480 1480 1600 
TGTCTCCcTGAAGAGTG?ACCCTCTTT~GTAAATGAA~CTAATCACT~AAAAAAAAA~AAAAAAAA 
1620 1640 1660 
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recombinants were screened at high stringency 
with the 430 bp PstI fragment of pMAti15 [27], 
containing the sequences for the N-terminal of the 
mouse muscle a-AChR subunit. Positive clones 
were plaque purified, and insert bearing plasmids 
were obtained using a helper phage following the 
supplier’s protocol. 
2.4. Analysis of cDNA clones 
Plasmid DNA was characterized by restriction 
enzyme digestion, followed by agarose gel elec- 
trophoresis and Southern blotting. 
For DNA sequencing, nested deletions were pro- 
duced by the EXO III/Mung Bean protocol 
(Stratagene) in both orientations. DNA sequencing 
was performed using a modification of the dideox- 
ynucleotide chain termination method of Sanger et 
al. [28]. 
3. RESULTS 
Northern blot analysis of total cellular poly(A)+ 
RNA (fig.1) revealed a single RNA species of ap- 
prox. 2 kb when probed with the mouse muscle 
AChR subunit cDNA clone pMAh15 [27] at high 
stringency (final washing 0.3 x SSPE at 65°C). 
Three larger RNA species >4 kb were visible after 
longer exposure (not shown). Hybridization with 
probes derived from cDNAs coding for the &, y- 
and a-subunits of the mouse muscle AChR also 
revealed one major RNA species for each probe, 
suggesting that ,&, y- and d-subunits are also ex- 
pressed (Luther, M. et al., in preparation). 
To analyze the primary structure of the a- 
subunit, a cDNA library was constructed. Screen- 
ing of approx. lo5 recombinants allowed the isola- 
tion of four overlapping clones harboring inserts 
> 1.3 kb. Two clones, TE 1.1 and TE 4.1 (fig.2), 
were analyzed by DNA sequencing. The 3 ‘-end of 
the 1686 bp insert of TE 1.1 is probably the result 
of an oligo(A) stretch present in the genomic se- 
quence [22] that might have been the priming site 
for the cDNA synthesis. The poly(A) tail in TE 4.1 
follows the polyadenylation signal AATAAA. The 
5’-end of TE 4.1 represents equences of intron 3. 
Nucleotide sequence (fig.3) comparison of TE 1.1 
with the predicted exons of the human muscle 
genomic a-subunit sequence [22] revealed 100% 
identity. This confirms that TE67 1 expresses exact- 
ly the same human gene which is thought to code 
for the functional muscle a-subunit. This is based 
on the > 95% sequence identity of the human mus- 
cle a-subunit with those from calf and mouse mus- 
cle a-subunits, both of which have been shown to 
function in oocyte expression systems [29,30]. 
4. DISCUSSION 
The deduced amino acid sequence of TE 1 .l 
shows the typical features of an ACh-binding 
subunit of muscle AChRs. It exhibits 95% amino 
acid sequence identity to a-subunits of AChR from 
mouse muscle [27]. A hydrophobic leader sequence 
of twenty amino acids, four hydrophobic segments 
M 1 -M4, and two extracellular cysteines at 128 and 
142 (presumably linked by a disulfide bridge) are 
January 1988 
Table 1 
Binding of mAbs on Western blots to Torpedo and human AChR cu-subunits 
mAb no. mAb 
binding site 
Sequence Binding on 
Western blots 
to a-subunit 
3s Torpedo ~~349-357 Torpedo: S D I S G K Q V T + 
human:. . . . . . PGP _ 
142 Torpedo ~~353-359 Torpedo: G K Q V T G E + 
human:. . PGPPP _ 
152,153, Torpedo ~~371-378 Torpedo: D V K S A I E G + 
155,157, human: E . . . . . . + 
164 
mAb binding sites from [35]. (Dot) Amino acid as in Torpedo sequence 
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present. The adjacent disulfide linked cysteines 
192-193 are unique to the a-subunit and can be af- 
finity labeled with MBTA [3,31]. The a-subunit of 
the AChR of TE671 can also be affinity labeled 
with MBTA (Luther, M. et al., in preparation). 
The sequence of the ACh-binding subunit of 
AChRs from TE671 is quite distinct from that of 
the ACh-binding subunit of rat neuronal AChRs, 
although they both have a leader sequence, 
hydrophobic segments Ml-M4 and cysteines at 
128, 142, 192 and 193. It exhibits only 51(rlo amino 
acid sequence identity with a cDNA identified in 
PC12 cells [32] and 47% sequence identity with a 
cDNA identified in rat brain [lo]. This rat brain 
cDNA is known to correspond to the ACh-binding 
subunit of AChR purified from rat brain [9]. 
Muscle-type AChR protein was not detected in 
human brain immunologically [21], nor has muscle 
a-subunit mRNA been detected in rat brain 
(Boulter, J., personal communication). 
Why is muscle AChR expressed in a neuronal 
cell line? It is interesting to remember that the 
BC3Hl mouse cell line which is studied as a model 
muscle AChR was derived from a CNS tumor and 
only partially exhibits skeletal muscle morphology 
[33]. One possible explanation for why TE671 ex- 
presses muscle AChR may be that this cell line 
arises from the immortalization of a neuronal cell 
type expressed transiently during development, but 
not in adult brain. Conditions have been found 
which can either up-regulate AChR expression in 
this cell line or down-regulate xpression of AChR 
while stopping division and inducing a neuronal 
morphology with greatly extended processes 
(Luther, M. et al., in preparation). This may be 
analogous to the effect of a normal developmental 
inducer which suppresses muscle AChR synthesis 
and induces terminal neuronal differentiation. 
Although m-subunits of AChRs from Torpedo 
and human muscle have 80% amino acid sequence 
identity [22], AChRs from these species exhibit 
<5% serum antibody crossreactivity [34]. 
Monoclonal antibodies (mAbs) which bind to 
epitopes formed by contiguous amino acid se- 
quences can also clearly discriminate between LY- 
subunits of the two species, as shown by the ex- 
amples in table 1. 
Torpedo AChR a-subunit cDNA clones have 
been expressed in fragments in bacteria [36,37], as 
full-length clones in yeast [38] and cell lines 
[39,40]. The proteins in bacteria have been used to 
map the aBgt-binding site [36,37] and epitopes 
recognized by T cells in experimental autoimmune 
MG (EAMG) and MG (Melmes, A. et al., personal 
communication). Blount and Merlie [40] showed 
that the BC3Hl a-subunit expressed in quail 
fibroblast acquires the main immunogenic region 
(MIR), a highly conformation-dependent epitope 
against which the majority of antibodies in EAMG 
and MG are directed [41]. 
a-subunits are very important in the autoim- 
mune response to AChR which occurs in MG 
because denatured u-subunit epitopes predominate 
in T lymphocyte recognition of AChRs [42,43], 
and because conformation-dependent a-subunit 
epitopes predominate in B lymphocyte recognition 
of AChRs ([41] and review [44]). Although electric 
organ provides large amounts of AChR for studies 
of EAMG, human AChR for studies of species- 
specific autoimmune responses in MG has been 
available in only negligible amounts from extracts 
of amputated leg muscle. TE671 cells provide a far 
richer source of human muscle AGhR, but still 
submilligram amounts. From suitable expression 
systems, a-subunits from TE671 cells may in the 
future be prepared in both desirable conforma- 
tions and large amounts, with great benefit for 
studies of MG. 
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